At the time of writing, Bausch Health Companies Inc [BHC] stock is trading at $6.66, up 3.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BHC shares have gain 9.18% over the last week, with a monthly amount glided 44.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bausch Health Companies Inc [NYSE: BHC] stock has seen the most recent analyst activity on August 02, 2024, when Piper Sandler downgraded its rating to a Underweight and also revised its price target to $3 from $9. Previously, Raymond James started tracking the stock with Mkt Perform rating on July 10, 2024, and set its price target to $8. On September 20, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $16 on the stock. TD Cowen downgraded its rating to a Market Perform. Truist downgraded its rating to a Hold. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on July 29, 2022, and downed its price target to $5. In a note dated July 28, 2022, JP Morgan downgraded an Neutral rating on this stock.
For the past year, the stock price of Bausch Health Companies Inc fluctuated between $3.96 and $9.85. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Bausch Health Companies Inc [NYSE: BHC] shares were valued at $6.66 at the most recent close of the market. An investor can expect a potential return of 50.15% based on the average BHC price forecast.
Analyzing the BHC fundamentals
According to Bausch Health Companies Inc [NYSE:BHC], the company’s sales were 9.73B for trailing twelve months, which represents an 4.92% jump. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is 0.05 and Total Capital is 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.44 points at the first support level, and at 6.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.84, and for the 2nd resistance point, it is at 7.01.
Ratios To Look Out For
It is important to note that Bausch Health Companies Inc [NYSE:BHC] has a current ratio of 1.35. In addition, the Quick Ratio stands at 0.97. Considering the valuation of this stock, the price to sales ratio is 0.25.
Transactions by insiders
Recent insider trading involved Paulson John, Director, that happened on Jun 13 ’25 when 3.56 million shares were purchased. Director, Paulson John completed a deal on Jun 12 ’25 to buy 1.01 million shares. Meanwhile, Director Paulson John bought 1.03 million shares on Jun 11 ’25.
